國立虎尾科技大學 |

Molecular Targeted Radiosensitizers = Opportunities and Challenges /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Molecular Targeted Radiosensitizers/ edited by Henning Willers, Iris Eke.
其他題名:	Opportunities and Challenges /
其他作者:	Eke, Iris.
面頁冊數:	XI, 364 p. 42 illus., 38 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology/Toxicology. -
電子資源:	https://doi.org/10.1007/978-3-030-49701-9
ISBN:	9783030497019

Molecular Targeted Radiosensitizers = Opportunities and Challenges /
Molecular Targeted RadiosensitizersOpportunities and Challenges /[electronic resource] :edited by Henning Willers, Iris Eke. - 1st ed. 2020. - XI, 364 p. 42 illus., 38 illus. in color.online resource. - Cancer Drug Discovery and Development,2196-9906. - Cancer Drug Discovery and Development,.

Introduction to Molecular Targeted Radiosensitizers: Opportunities and Challenges -- Translating Targeted Radiosensitizers into the Clinic -- Cartography of the Radiogenome of Human Cancers -- Mechanisms and Markers of Clinical Radioresistance -- Preclinical Strategies for Testing of Targeted Radiosensitizers -- 3D Radiation Biology for Identifying Radiosensitizers -- Preclinical in vivo evaluation of novel radiosensitizers by local tumor control experiments -- Genetically Engineered Mouse Models for Studying Radiation Biology and Radiosensitizers -- Targeting the DNA Damage Response for Radiosensitization -- Targeting Tumor Metabolism to Overcome Radioresistance.-Targeting Tumor Hypoxia -- Normalizing the Tumor Microenvironment for Radiosensitization -- Radiosensitizers in the Era of Immuno-Oncology -- Index.

Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionally, the book features discussions on high-throughput drug screening, predictive biomarkers, pre-clinical tumor models, and the influence of the tumor microenvironment and the immune system, with a specific focus on the challenges radiation oncologists and medical oncologists currently face in testing radiosensitizers in human cancers. Edited by two acclaimed experts in radiation biology and radiosensitizers, with thirteen chapters contributed by experts, this new volume presents an in-depth look at current developments within a rapidly moving field, with a look at where the field will be heading and providing comprehensive insight into the framework of targeted radiosensitzer development. Essential reading for investigators in cancer research and radiation biology.

ISBN: 9783030497019

Standard No.: 10.1007/978-3-030-49701-9doiSubjects--Topical Terms:

593882
Pharmacology/Toxicology.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Molecular Targeted Radiosensitizers = Opportunities and Challenges /
LDR:03720nam a22004095i 4500 001 1021824
003 DE-He213
005 20200810184754.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030497019 $9 978-3-030-49701-9
024 7 $a 10.1007/978-3-030-49701-9 $2 doi
035 $a 978-3-030-49701-9
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Molecular Targeted Radiosensitizers $h [electronic resource] : $b Opportunities and Challenges / $c edited by Henning Willers, Iris Eke.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2020.
300 $a XI, 364 p. 42 illus., 38 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Drug Discovery and Development, $x 2196-9906
505 0 $a Introduction to Molecular Targeted Radiosensitizers: Opportunities and Challenges -- Translating Targeted Radiosensitizers into the Clinic -- Cartography of the Radiogenome of Human Cancers -- Mechanisms and Markers of Clinical Radioresistance -- Preclinical Strategies for Testing of Targeted Radiosensitizers -- 3D Radiation Biology for Identifying Radiosensitizers -- Preclinical in vivo evaluation of novel radiosensitizers by local tumor control experiments -- Genetically Engineered Mouse Models for Studying Radiation Biology and Radiosensitizers -- Targeting the DNA Damage Response for Radiosensitization -- Targeting Tumor Metabolism to Overcome Radioresistance.-Targeting Tumor Hypoxia -- Normalizing the Tumor Microenvironment for Radiosensitization -- Radiosensitizers in the Era of Immuno-Oncology -- Index.
520 $a Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionally, the book features discussions on high-throughput drug screening, predictive biomarkers, pre-clinical tumor models, and the influence of the tumor microenvironment and the immune system, with a specific focus on the challenges radiation oncologists and medical oncologists currently face in testing radiosensitizers in human cancers. Edited by two acclaimed experts in radiation biology and radiosensitizers, with thirteen chapters contributed by experts, this new volume presents an in-depth look at current developments within a rapidly moving field, with a look at where the field will be heading and providing comprehensive insight into the framework of targeted radiosensitzer development. Essential reading for investigators in cancer research and radiation biology.
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 1 4 $a Cancer Research. $3 668358
650 0 $a Pharmacology. $3 583819
650 0 $a Radiotherapy. $3 593952
650 0 $a Cancer research. $3 1253664
700 1 $a Eke, Iris. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1317513
700 1 $a Willers, Henning. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1317512
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030497002
776 0 8 $i Printed edition: $z 9783030497026
776 0 8 $i Printed edition: $z 9783030497033
830 0 $a Cancer Drug Discovery and Development, $x 2196-9906 $3 1253870
856 4 0 $u https://doi.org/10.1007/978-3-030-49701-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)